IRVINE, Calif., April 22, 2019 — Ascendiant Capital Markets, LLC (“Ascendiant”) announced today the initiation of research coverage on Outlook Therapeutics, Inc. (NasdaqCM: OTLK) of Cranbury, New Jersey. For a copy of the initiation report, please click here.